U.S. Markets closed
  • S&P Futures

    3,965.25
    +3.25 (+0.08%)
     
  • Dow Futures

    33,882.00
    +25.00 (+0.07%)
     
  • Nasdaq Futures

    11,534.00
    +9.25 (+0.08%)
     
  • Russell 2000 Futures

    1,839.90
    +2.10 (+0.11%)
     
  • Crude Oil

    78.77
    +0.57 (+0.73%)
     
  • Gold

    1,766.30
    +2.60 (+0.15%)
     
  • Silver

    21.45
    +0.01 (+0.07%)
     
  • EUR/USD

    1.0348
    +0.0013 (+0.1242%)
     
  • 10-Yr Bond

    3.7480
    +0.0450 (+1.22%)
     
  • Vix

    21.89
    -0.32 (-1.44%)
     
  • GBP/USD

    1.1976
    +0.0026 (+0.2204%)
     
  • USD/JPY

    138.6130
    -0.0210 (-0.0151%)
     
  • BTC-USD

    16,906.33
    +642.90 (+3.95%)
     
  • CMC Crypto 200

    401.65
    +12.93 (+3.33%)
     
  • FTSE 100

    7,512.00
    +37.98 (+0.51%)
     
  • Nikkei 225

    27,854.62
    -173.22 (-0.62%)
     

A Technical Strategy to 'Buy' Agios Pharmaceuticals

A Technical Strategy to 'Buy' Agios Pharmaceuticals

Agios Pharmaceuticals is pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias (a blood condition that occurs when your red blood cells are destroyed faster than they can be replaced). In this daily bar chart we can see a price decline to a June low followed by a rally above the 50-day moving average line and the slower-to-react 200-day line. The On-Balance-Volume (OBV) line shows a decline into a June low followed by a rising pattern telling us that AGIO traders have shifted from aggressive sellers to aggressive buyers.